תאריך: 07/01/2010
Treatment options for patients with chronic refractory immune thrombocytopenic
purpura (ITP) are limited. Because combination immunosuppressant therapy
appeared to be effective in ITP and other disorders, we used this approach in patients
with particularly severe and refractory ITP.
BLOOD, 7 JANUARY 2010 , VOLUME 115, NUMBER 1
